Clinical characteristics of very old patients hospitalized in internal medicine wards for heart failure: a sub-analysis of the FADOI-CONFINE Study Group

被引:5
作者
Biagi, Paolo [1 ]
Nardi, Roberto [2 ]
Baldo, Concetta Isabella [3 ]
Scanelli, Giovanni [4 ]
Panuccio, Domenico [5 ]
Bonanome, Andrea [6 ]
Miserocchi, Fabio [7 ]
Lusiani, Luigi [8 ]
Bonizzoni, Erminio [9 ]
Campanini, Mauro [10 ]
Nozzoli, Carlo
Vescovo, Giorgio [11 ]
机构
[1] Hosp Montepulciano, Internal Med, Montepulciano, Italy
[2] Maggiore Hosp, Internal Med C, Bologna, Italy
[3] FADOI Fdn, Res Dept, Milan, Italy
[4] Arcispedale SantAnna, Internal Med, Ferrara, Italy
[5] Maggiore Hosp, Internal Med B, Bologna, Italy
[6] S Giovanni & S Paolo Hosp, Internal Med, Venice, Italy
[7] Hosp Valdagno, Internal Med, Valdagno, Italy
[8] Hosp Castelfranco Veneto, Internal Med, Castelfranco, Veneto, Italy
[9] Univ Milan, Inst Med Stat & Biometry, Milan, Italy
[10] AOU Maggiore Carita, Internal Med, Novara, Italy
[11] AOU Careggi, Dept Internal Med, Florence, Italy
[12] San Bortolo Hosp, Internal Med, Vicenza, Italy
关键词
very old patients; Internal Medicine; heart failure; therapy;
D O I
10.4081/itjm.2014.394
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence and prevalence of chronic heart failure are increasing worldwide, as is the number of very old patients (>85 years) affected by this disease. The aim of this sub-analysis of the multicenter, observational CONFINE study was to detect clinical and therapeutic peculiarities in patients with chronic heart failure aged >85 years. We recruited patients admitted with a diagnosis of chronic heart failure and present in the hospital in five index days, in 91 Units of Internal Medicine. The patients' clinical characteristics, functional and cognitive status, and the management of the heart failure were analyzed. A total of 1444 subjects were evaluated, of whom 329 (23.1%) were over 85 years old. Signs and symptoms of chronic heart failure were more common in very old patients, as were severe renal insufficiency, anemia, disability and cognitive impairment. The present survey found important age-related differences (concomitant diseases, cognitive status) among patients with chronic heart failure, as well as different therapeutic strategies and clinical outcome for patients over 85 years old. Since these patients are usually excluded from clinical trials and their management remains empirical, specific studies focused on the treatment of very old patients with chronic heart failure are needed.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 25 条
  • [21] Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/pharmacodynamics study
    Tominaga, Naoto
    Kida, Keisuke
    Matsumoto, Naoki
    Akashi, Yoshihiro J.
    Miyake, Fumihiko
    Kimura, Kenjiro
    Shibagaki, Yugo
    CLINICAL NEPHROLOGY, 2015, 84 (01) : 29 - 38
  • [22] The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study
    Kitada, Shuichi
    Kikuchi, Shohei
    Tsujino, Takeshi
    Masuyama, Tohru
    Ohte, Nobuyuki
    ESC HEART FAILURE, 2018, 5 (01): : 36 - 45
  • [23] Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study
    Di Somma, Salvatore
    Marino, Rossella
    Zampini, Giorgio
    Magrini, Laura
    Ferri, Enrico
    Shah, Kevin
    Clopton, Paul
    Maisel, Alan S.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (03) : 507 - 513
  • [24] Cross-sectional study of heart failure of patients intaked in an Internal Medicine Service in the third level hospital in mixed area.: Part III:: Mortality analysis
    Sanjurjo, S. Cinza
    De Barron, A. Cabarcos Ortiz
    Pol, E. Nieto
    Carballada, J. A. Torre
    ANALES DE MEDICINA INTERNA, 2007, 24 (08) : 379 - 383
  • [25] Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/ neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
    Aiglova, Renata
    Taborsky, Milos
    Lazarova, Marie
    Pavlu, Ludek
    Danek, Josef
    Precek, Jan
    Schee, Alexander
    Gloger, Vit
    Cernicek, Vlastimil
    Vicha, Marek
    Skala, Tomas
    BIOMEDICAL PAPERS-OLOMOUC, 2022, 166 (03): : 322 - 327